BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 2671490)

  • 1. Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis. Relationship of familial nephritis and Goodpasture antigens to novel collagen chains and type IV collagen.
    Kleppel MM; Kashtan C; Santi PA; Wieslander J; Michael AF
    Lab Invest; 1989 Sep; 61(3):278-89. PubMed ID: 2671490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.
    Yoshioka K; Hino S; Takemura T; Maki S; Wieslander J; Takekoshi Y; Makino H; Kagawa M; Sado Y; Kashtan CE
    Am J Pathol; 1994 May; 144(5):986-96. PubMed ID: 8178947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The non-collagenous domains of the alpha 3 and 4 chains of type IV collagen and their relationship to the Goodpasture antigen.
    Savige JA; Gallicchio M
    Clin Exp Immunol; 1991 Jun; 84(3):454-8. PubMed ID: 2044225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
    Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
    J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of type IV collagen NC1 monomers and Goodpasture antigen in human renal basement membranes.
    Butkowski RJ; Shen GQ; Wieslander J; Michael AF; Fish AJ
    J Lab Clin Med; 1990 Mar; 115(3):365-73. PubMed ID: 1690255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Samoyed hereditary glomerulopathy. Immunohistochemical staining of basement membranes of kidney for laminin, collagen type IV, fibronectin, and Goodpasture antigen, and correlation with electron microscopy of glomerular capillary basement membranes.
    Thorner P; Jansen B; Baumal R; Valli VE; Goldberger A
    Lab Invest; 1987 Apr; 56(4):435-43. PubMed ID: 3550289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis.
    Kashtan C; Fish AJ; Kleppel M; Yoshioka K; Michael AF
    J Clin Invest; 1986 Oct; 78(4):1035-44. PubMed ID: 2428839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glomerular basement membrane defect in Alport-type hereditary nephritis: absence of cationic antigenic components.
    van den Heuvel LP; Savage CO; Wong M; Price RG; Noel L; Grunfeld JP; Lockwood CM
    Nephrol Dial Transplant; 1989; 4(9):770-5. PubMed ID: 2483255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistologic studies of type IV collagen in anterior lens capsules of patients with Alport syndrome.
    Cheong HI; Kashtan CE; Kim Y; Kleppel MM; Michael AF
    Lab Invest; 1994 Apr; 70(4):553-7. PubMed ID: 8176894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunofluorescence study of type IV collagen alpha chains in epidermal basement membrane: application in diagnosis of X-linked Alport syndrome.
    Ding J; Yang J; Liu J; Yu L
    Chin Med J (Engl); 1997 Aug; 110(8):584-6. PubMed ID: 9594257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allograft rejection and glomerular basement membrane antibodies in Alport's syndrome.
    Charytan D; Torre A; Khurana M; Nicastri A; Stillman IE; Kalluri R
    J Nephrol; 2004; 17(3):431-5. PubMed ID: 15365966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
    Brainwood D; Kashtan C; Gubler MC; Turner AN
    Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical studies of the Alport antigen.
    Kleppel MM; Fan WW; Cheong HI; Kashtan CE; Michael AF
    Kidney Int; 1992 Jun; 41(6):1629-37. PubMed ID: 1501419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
    Borza DB; Hudson BG
    Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-specific distribution of the Goodpasture antigen demonstrated by 2-D electrophoresis and western blotting.
    Derry CJ; Pusey CD
    Nephrol Dial Transplant; 1994; 9(4):355-61. PubMed ID: 8084446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis of Alport syndrome involves type IV collagen molecules containing the alpha 3(IV) chain: evidence from anti-GBM nephritis after renal transplantation.
    Hudson BG; Kalluri R; Gunwar S; Weber M; Ballester F; Hudson JK; Noelken ME; Sarras M; Richardson WR; Saus J
    Kidney Int; 1992 Jul; 42(1):179-87. PubMed ID: 1635348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the Goodpasture antigen, alpha 3(IV) NC1, and four other NC1 domains of type IV collagen, by amino-terminal sequence analysis of human glomerular basement membrane separated by two-dimensional electrophoresis.
    Derry CJ; Pickering M; Baker C; Pusey CD
    Exp Nephrol; 1994; 2(4):249-56. PubMed ID: 7520821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the NC1 domain of collagen type IV in glomerular basement membranes (GBM) and of antibodies to GBM in a patient with anti-GBM nephritis.
    Thorner PS; Baumal R; Eddy A; Marrano P
    Clin Nephrol; 1989 Mar; 31(3):160-8. PubMed ID: 2706812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of novel basement membrane components in the developing human kidney and eye.
    Kleppel MM; Michael AF
    Am J Anat; 1990 Feb; 187(2):165-74. PubMed ID: 2301276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinicopathological study of Alport syndrome and detection of type IV collagen chains in Alport patients.
    Chen N; Pan X; Ren H; Dong D
    Chin Med J (Engl); 1998 Sep; 111(9):797-802. PubMed ID: 11155669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.